Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period

Circulation

Volumn 132, Issue 18, 2015, Pages 1726-1733

  Goel, Arvind ^a   Maski, Manish R ^a   Bajracharya, Surichhya ^a   Wenger, Julia B ^a   Zhang, Dongsheng ^a   Salahuddin, Saira ^a   Shahul, Sajid S ^a   Thadhani, Ravi ^a   Seely, Ellen W ^a   Karumanchi, S Ananth ^a,b   Rana, Sarosh ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Angiogenesis; Hypertension; Postpartum; Pre eclampsia; Pregnancy; Receptors, vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; ANTIHYPERTENSIVE AGENT; PLACENTAL GROWTH FACTOR; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG; FLT1 PROTEIN, HUMAN; PLACENTA PROTEIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CESAREAN SECTION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SYSTOLIC BLOOD PRESSURE; TERTIARY CARE CENTER; BLOOD; DIABETES, GESTATIONAL; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; LENGTH OF STAY; OBESITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PRE-ECLAMPSIA; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS; PUERPERAL DISORDERS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; CESAREAN SECTION; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; LENGTH OF STAY; OBESITY; POSTOPERATIVE COMPLICATIONS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS; PREGNANCY PROTEINS; PUERPERAL DISORDERS; RETROSPECTIVE STUDIES; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84947128304     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.015721     Document Type: Article

References (22)

1. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066-1074. doi: 10.1016/S0140-6736(06)68397-9.
2. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974. doi: 10.1136/bmj.39335.385301.BE.
3. Magee L, von Dadelszen P. Prevention and treatment of postpartum hypertension. Cochrane Database Syst Rev. 2013;4:CD004351. doi: 10.1002/14651858.CD004351.pub3.
4. Sibai BM. Etiology and management of postpartum hypertension-pre-eclampsia. Am J Obstet Gynecol. 2012;206:470-475. doi: 10.1016/j. ajog.2011.09.002.
5. Al-Saf Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol. 2011;118:1102-1107. doi: 10.1097/AOG.0b013e318231934c.
6. Bateman BT, Schumacher HC, Bushnell CD, Pile-Spellman J, Simpson LL, Sacco RL, Berman MF. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology. 2006;67:424-429. doi: 10.1212/01.wnl.0000228277.84760.a2.
7. Cohen J, Vaiman D, Sibai BM, Haddad B. Blood pressure changes during the frst stage of labor and for the prediction of early postpartum preeclampsia: a prospective study. Eur J Obstet Gynecol Reprod Biol. 2015;184:103-107. doi: 10.1016/j.ejogrb.2014.11.020.
8. Hirshfeld-Cytron J, Lam C, Karumanchi SA, Lindheimer M. Late postpar-tum eclampsia: examples and review. Obstet Gynecol Surv. 2006;61:471-480. doi: 10.1097/01.ogx.0000219564.65999.0d.
9. Ghuman N, Rheiner J, Tendler BE, White WB. Hypertension in the postpartum woman: clinical update for the hypertension specialist. J Clin Hypertens (Greenwich). 2009;11:726-733. doi: 10.1111/j.1751-7176.2009.00186.x.
10. Nagai K, Ikenoue T, Mori N. Atrial natriuretic peptide in transient puerperal hypertension. J Matern Fetal Med. 1997;6:329-333. doi: 10.1002/(SICI)1520-6661(199711/12)6:63.0.CO;2-Q.
11. Saxena AR, Karumanchi SA, Brown NJ, Royle CM, McElrath TF, Seely EW. Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension. 2010;55:1239-1245. doi: 10.1161/HYPERTENSIONAHA.109.147595.
12. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and pro-teinuria in preeclampsia. J Clin Invest. 2003;111:649-658. doi: 10.1172/JCI17189.
13. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme V P, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672-683. doi: 10.1056/NEJMoa031884.
14. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA; CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005. doi: 10.1056/NEJMoa055352.
15. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012;125:911-919. doi: 10.1161/CIRCULATIONAHA.111.054361.
16. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA. A longitudinal study of angiogenic (pla-cental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21:9-23. doi: 10.1080/14767050701830480.
17. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122:478-487. doi: 10.1161/CIRCULATIONAHA.109.895458.
18. Walters BN, Thompson ME, Lee A, de Swiet M. Blood pressure in the puerperium. Clin Sci (Lond). 1986;71:589-594.
19. Tan LK, de Swiet M. The management of postpartum hypertension. BJOG. 2002;109:733-736.
20. Cruz MO, Gao W, Hibbard JU. Obstetrical and perinatal outcomes among women with gestational hypertension, mild preeclampsia, and mild chronic hypertension. Am J Obstet Gynecol. 2011;205:260.e1-260.e9. doi: 10.1016/j.ajog.2011.06.033.
21. Matthys LA, Coppage KH, Lambers DS, Barton JR, Sibai BM. Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol. 2004;190:1464-1466. doi: 10.1016/j.ajog.2004.02.037.
22. Podymow T, August P. Postpartum course of gestational hypertension and preeclampsia. Hypertens Pregnancy. 2010;29:294-300. doi: 10.3109/10641950902777747.